ladbible homepage
ladbible homepage
  • Home
  • News
    • UK
    • US
    • World
    • Ireland
    • Australia
    • Science
    • Crime
    • Weather
  • Entertainment
    • Celebrity
    • TV
    • Film
    • Music
    • Gaming
    • Netflix
    • Disney
  • Sport
  • Technology
  • Travel
  • Lifestyle
  • Money
  • Originals
    • FFS PRODUCTIONS
    • Say Maaate to a Mate
    • Daily Ladness
    • UOKM8?
    • FreeToBe
    • Citizen Reef
  • Advertise
  • Terms
  • Privacy & Cookies
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Archive
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
Snapchat
TikTok
YouTube
Submit Your Content Here
  • SPORTbible
  • Tyla
  • GAMINGbible
  • LADbible Group
  • UNILAD
  • FOODbible
  • UNILAD Tech
Common drug could help stop food allergies from killing you
Home>News>Health
Updated 10:01 27 Feb 2024 GMTPublished 10:03 27 Feb 2024 GMT

Common drug could help stop food allergies from killing you

The medicine was given to children who were severely allergic to peanuts

Tom Earnshaw

Tom Earnshaw

google discoverFollow us on Google Discover

A drug is being hailed as a 'breakthrough' in the fight against allergic reactions, with it potentially having the capacity to save lives.

Researchers have been looking in to the effectiveness of a medicine when someone consumes a small amount of a substance they are allergic to.

The findings have been published in a new study documented by The New England Journal of Medicine.

The drug - called omalizumab - was tested on adults and children who had peanut allergies and at least allergies to two other foods.

Advert

Allergies can really hinder a person's quality of life.
Getty Stock Images

In the UK and US, omalizumab had already been prescribed as Xolair and given to patients with chronic idiopathic urticaria, hives, and asthma.

In total, three adults and 177 children aged between one and 17 underwent tests.

The research showed that after around four months of taking omalizumab, two thirds (67%) of those on the drug would ingest the equivalent of two to three peanuts without significant reaction.

It was only 7% for those who had the placebo.

As well as this, 14% of those who took omalizumab were still unable to eat even a fraction of one peanut without having a reaction.

Peanut allergies can be incredibly serious.
Getty Stock Images

Ruchi Gupta, a paediatrician at Northwestern University Feinberg School of Medicine in Chicago, Illinois, told Nature: "This is a huge breakthrough for food-allergy treatment.

"Having treatments that can make people feel safer [while eating] is just wonderful. Having new choices for treatments is really just going to help this field so much."

The research was enough for the US Food and Drug Administration (FDA) to approve omalizumab as a treatment for food allergies earlier earlier this month.

The research regarding food allergies could prove to be huge in improving the quality of life for those with other allergies such as peanuts.

The NHS says the drug 'has been shown to decrease the number of asthma attacks in patients with more moderate to severe asthma, and in some patients it allows a reduction of other asthma medications'.

Omalizumab could offer a real hope to those with food allergies.
Getty Stock Images

The new study in the US didn't find any adverse side effects, but there was a footnote that it could make a person's natural defence to parasitic worms lower. Nasty.

The NHS says that research shows it carries a small risk of developing blood clots in the legs, lungs, heart and brain.

The study also stresses it's not a cure, but rather a way to increase your threshold should you eat something with the allergic food in it.

It adds you 'must continue to avoid foods they are allergic to'.

Featured Image Credit: Getty Stock Images

Topics: Good News, Health, News, US News, Science, Food And Drink

Tom Earnshaw
Tom Earnshaw

Tom joined LADbible Group in 2024, currently working as SEO Lead across all brands including LADbible, UNILAD, SPORTbible, Tyla, UNILAD Tech, and GAMINGbible. He moved to the company from Reach plc where he enjoyed spells as a content editor and senior reporter for one of the country's most-read local news brands, LancsLive. When he's not in work, Tom spends his adult life as a suffering Manchester United supporter after a childhood filled with trebles and Premier League titles. You can't have it all forever, I suppose.

X

@TREarnshaw

Recommended reads

Gina Carano lost million-dollar Star Wars deal over one social media postPatrick T. Fallon / AFP via Getty ImagesNew study finds weight loss jabs could halve the number of sick days people take off workGetty Stock PhotoHayden Panettiere says she was 'groomed' as she opens up on dark side of growing up in HollywoodJon Kopaloff/Getty Images'Super El Nino' wiped out nearly all life in event worse than dinosaur apocalypseX/@forallcurious

Advert

  • Heart doctor shares warning over food ‘worse than smoking’ that decreases lifespan
  • Heart surgeon issues warning against food eaten by millions daily ‘destroying your heart'
  • NHS list of nine questions determine if you could be high functioning alcoholic
  • Neurologist revealed the exact age you should stop drinking beer

Choose your content:

12 hours ago
14 hours ago
15 hours ago
  • Getty Stock Photo
    12 hours ago

    New study finds weight loss jabs could halve the number of sick days people take off work

    A new study says it could free up millions of GP appointments too

    News
  • X/@forallcurious
    12 hours ago

    'Super El Nino' wiped out nearly all life in event worse than dinosaur apocalypse

    An 'El Nino' is a devastating weather phenomenon

    News
  • Mohamad Salaheldin Abdelg Alsayed/Anadolu via Getty Images
    14 hours ago

    Huge update on two orcas 'left for dead' in abandoned marine park

    The mother and son orcas might be able to be saved

    News
  • Getty Stock
    15 hours ago

    Common supplement could prolong your life by slowing down biological clock

    A new study examined the impact of the supplements over a two year period

    News